IPO Update: 58 Drug Developers Raised $12.5bn Through Q3
With Three More In Q4, 2020 Total Reaches 61
Executive Summary
The average return for companies that went public in the US through the end of September was 49.4% as of 5 October. The fourth quarter started with three additional initial public offerings on 1 October.